ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · Real-Time Price · USD
18.26
-0.27 (-1.46%)
Dec 20, 2024, 4:00 PM EST - Market closed
-1.46%
Assets $4.05M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 221,096
Dividend (ttm) $0.65
Dividend Yield 3.55%
Ex-Dividend Date Sep 25, 2024
Payout Ratio n/a
1-Year Return -5.68%
Volume 14,341
Open 18.39
Previous Close 18.53
Day's Range 17.92 - 18.39
52-Week Low 14.05
52-Week High 21.10
Beta -1.11
Holdings 8
Inception Date Apr 8, 2010

About BIS

Fund Home Page

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Inverse Equity
Stock Exchange NASDAQ
Ticker Symbol BIS
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Dividends

Ex-Dividend Amount Pay Date
Sep 25, 2024 $0.152 Oct 2, 2024
Jun 26, 2024 $0.161 Jul 3, 2024
Mar 20, 2024 $0.159 Mar 27, 2024
Dec 20, 2023 $0.176 Dec 28, 2023
Sep 20, 2023 $0.119 Sep 27, 2023
Jun 21, 2023 $0.021 Jun 28, 2023
Full Dividend History

News

Top Performing Leveraged/Inverse ETFs: 11/17/2024

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

4 weeks ago - ETF Trends

Purchase Levels Of 31 Short ETFs Signal Bear Market Bottom (Technical Analysis)

We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.

Other symbols: DOGDUGDXDMYYMZZPSQQID
2 years ago - Seeking Alpha